A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain

Clinical trial NCT07465029 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07465029
Sponsor: Bristol-Myers Squibb
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Lower-risk Myelodysplastic Syndromes (TD LR-MDS)

Start date: 2026-02-02
Primary completion: 2026-03-31
Enrollment: 1300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.